MOH

SEC source: 0001179929-25-000037 · wk-form4_1741138122.xml · nonDerivative · entry 4

Barlow Jeff D. · CIK 0001555603 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,817

F5 · shares: Grant of restricted stock under the Issuer's 2019 Equity Incentive Plan.

F6 · price: The volume-weighted average price (VWAP) of the Company's common stock for the ten (10) trading dates immediately preceding the March 1, 2025 grant date.

F7 · balance_after: The shares shall vest as follows: The 4,859 newly granted shares shall vest in one-third increments on each of March 1, 2026, March 1, 2027, and March 1, 2028. Additional shares shall vest as follows: 2,563 shares on March 1, 2026, and 1,102 shares on March 1, 2027. The remaining shares are vested.

SEC source: 0001179929-25-000037 · wk-form4_1741138122.xml · nonDerivative · entry 3

Barlow Jeff D. · CIK 0001555603 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,958

F4 · shares: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 3,738 shares on March 1, 2025.

F2 · price: Represents the closing price of the Issuer's common stock on February 28, 2025.

SEC source: 0001179929-25-000037 · wk-form4_1741138122.xml · nonDerivative · entry 2

Barlow Jeff D. · CIK 0001555603 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,809

F3 · shares: The shares were applied to payment of withholding taxes in connection with vesting of the above-mentioned performance stock units.

F2 · price: Represents the closing price of the Issuer's common stock on February 28, 2025.

SEC source: 0001179929-25-000037 · wk-form4_1741138122.xml · nonDerivative · entry 1

Barlow Jeff D. · CIK 0001555603 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,030

F1 · shares: Shares issued in settlement of performance stock units granted on March 1, 2022 based on the Company achievement of three-year average adjusted earnings per share at the 149% vesting level for the 2022 performance stock units.

F2 · price: Represents the closing price of the Issuer's common stock on February 28, 2025.

SEC source: 0001179929-25-000036 · wk-form4_1741138022.xml · nonDerivative · entry 4

Bacon Debra · CIK 0002010075 · EVP, Medicaid

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,026

F5 · shares: Grant of restricted stock under the Issuer's 2019 Equity Incentive Plan.

F6 · price: The volume-weighted average price (VWAP) of the Company's common stock for the ten (10) trading dates immediately preceding the March 1, 2025 grant date.

F7 · balance_after: The shares shall vest as follows: The 3,054 newly granted shares shall vest in one-third increments on each of March 1, 2026, March 1, 2027, and March 1, 2028. Additional shares shall vest as follows: 530 shares on July 1, 2025; 1,003 shares on March 1, 2026; 529 shares on July 1, 2026; and 757 shares on March 1, 2027. The remaining shares are vested.

SEC source: 0001179929-25-000036 · wk-form4_1741138022.xml · nonDerivative · entry 3

Bacon Debra · CIK 0002010075 · EVP, Medicaid

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,972

F4 · shares: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 1,249 shares on March 1, 2025.

F2 · price: Represents the closing price of the Issuer's common stock on February 28, 2025.

SEC source: 0001179929-25-000036 · wk-form4_1741138022.xml · nonDerivative · entry 2

Bacon Debra · CIK 0002010075 · EVP, Medicaid

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,403

F3 · shares: The shares were applied to payment of withholding taxes in connection with vesting of the above-mentioned performance stock units.

F2 · price: Represents the closing price of the Issuer's common stock on February 28, 2025.

SEC source: 0001179929-25-000036 · wk-form4_1741138022.xml · nonDerivative · entry 1

Bacon Debra · CIK 0002010075 · EVP, Medicaid

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,673

F1 · shares: Shares issued in settlement of performance stock units granted on March 1, 2022 based on the Company achievement of three-year average adjusted earnings per share at the 149% vesting level for the 2022 performance stock units.

F2 · price: Represents the closing price of the Issuer's common stock on February 28, 2025.

SEC source: 0001179929-25-000035 · wk-form4_1741137902.xml · nonDerivative · entry 4

HEBERT MAURICE · CIK 0001267043 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,208

F5 · shares: Grant of restricted stock under the Issuer's 2019 Equity Incentive Plan.

F6 · price: The volume-weighted average price (VWAP) of the Company's common stock for the ten (10) trading dates immediately preceding the March 1, 2025 grant date.

F7 · balance_after: The shares shall vest as follows: The 902 newly granted shares shall vest in one-third increments on each of March 1, 2026, March 1, 2027, and March 1, 2028. Additional shares shall vest as follows: 501 shares on March 1, 2026; and 258 shares on March 1, 2027. The remaining shares are vested.

SEC source: 0001179929-25-000035 · wk-form4_1741137902.xml · nonDerivative · entry 3

HEBERT MAURICE · CIK 0001267043 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,306

F4 · shares: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 901 shares on March 1, 2025.

F2 · price: Represents the closing price of the Issuer's common stock on February 28, 2025.

SEC source: 0001179929-25-000035 · wk-form4_1741137902.xml · nonDerivative · entry 2

HEBERT MAURICE · CIK 0001267043 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,609

F3 · shares: The shares were applied to payment of withholding taxes in connection with vesting of the above-mentioned performance stock units.

F2 · price: Represents the closing price of the Issuer's common stock on February 28, 2025.

SEC source: 0001179929-25-000035 · wk-form4_1741137902.xml · nonDerivative · entry 1

HEBERT MAURICE · CIK 0001267043 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,265

F1 · shares: Shares issued in settlement of performance stock units granted on March 1, 2022 based on the Company achievement of three-year average adjusted earnings per share at the 149% vesting level for the 2022 performance stock units.

F2 · price: Represents the closing price of the Issuer's common stock on February 28, 2025.

SEC source: 0001179929-25-000034 · wk-form4_1741137812.xml · nonDerivative · entry 4

WOYS JAMES · CIK 0001213947 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,246

F5 · shares: Grant of restricted stock under the Issuer's 2019 Equity Incentive Plan.

F6 · price: The volume-weighted average price (VWAP) of the Company's common stock for the ten (10) trading dates immediately preceding the March 1, 2025 grant date.

F7 · balance_after: The shares shall vest as follows: The 6,248 newly granted shares shall vest in one-third increments on each of March 1, 2026, March 1, 2027, and March 1, 2028. Additional shares shall vest as follows: 3,254 shares on March 1, 2026; and 1,549 shares on March 1, 2027. The remaining shares are vested.

SEC source: 0001179929-25-000034 · wk-form4_1741137812.xml · nonDerivative · entry 3

WOYS JAMES · CIK 0001213947 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,998

F4 · shares: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 4,643 shares on March 1, 2025.

F2 · price: Represents the closing price of the Issuer's common stock on February 28, 2025.

SEC source: 0001179929-25-000034 · wk-form4_1741137812.xml · nonDerivative · entry 2

WOYS JAMES · CIK 0001213947 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,597

F3 · shares: The shares were applied to payment of withholding taxes in connection with vesting of the above-mentioned performance stock units.

F2 · price: Represents the closing price of the Issuer's common stock on February 28, 2025.

SEC source: 0001179929-25-000034 · wk-form4_1741137812.xml · nonDerivative · entry 1

WOYS JAMES · CIK 0001213947 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,998

F1 · shares: Shares issued in settlement of performance stock units granted on March 1, 2022 based on the Company achievement of three-year average adjusted earnings per share at the 149% vesting level for the 2022 performance stock units.

F2 · price: Represents the closing price of the Issuer's common stock on February 28, 2025.

SEC source: 0001179929-25-000033 · wk-form4_1741137624.xml · nonDerivative · entry 4

Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 386,410

F5 · shares: Grant of restricted stock under the Issuer's 2019 Equity Incentive Plan.

F6 · price: The volume-weighted average price (VWAP) of the Company's common stock for the ten (10) trading dates immediately preceding the March 1, 2025 grant date.

F7 · balance_after: The shares shall vest as follows: The 22,491 newly granted shares shall vest in one-third increments on each of March 1, 2026, March 1, 2027, and March 1, 2028. Additional shares shall vest as follows: 13,127 shares on March 1, 2026 and 5,577 shares on March 1, 2027. The remaining shares are vested.

SEC source: 0001179929-25-000033 · wk-form4_1741137624.xml · nonDerivative · entry 3

Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 363,919

F4 · shares: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 19,539 shares on March 1, 2025.

F2 · price: Represents the closing price of the Issuer's common stock on February 28, 2025.

SEC source: 0001179929-25-000033 · wk-form4_1741137624.xml · nonDerivative · entry 2

Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 372,955

F3 · shares: The shares were applied to payment of withholding taxes in connection with vesting of the above-mentioned performance stock units.

F2 · price: Represents the closing price of the Issuer's common stock on February 28, 2025.

SEC source: 0001179929-25-000033 · wk-form4_1741137624.xml · nonDerivative · entry 1

Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 392,948

F1 · shares: Shares issued in settlement of performance stock units granted on March 1, 2022 based on the Company achievement of three-year average adjusted earnings per share at the 149% vesting level for the 2022 performance stock units.

F2 · price: Represents the closing price of the Issuer's common stock on February 28, 2025.

SEC source: 0001179929-25-000032 · wk-form4_1741137540.xml · nonDerivative · entry 4

Keim Mark Lowell · CIK 0001690677 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,486

F5 · shares: Grant of restricted stock under the Issuer's 2019 Equity Incentive Plan.

F6 · price: The volume-weighted average price (VWAP) of the Company's common stock for the ten (10) trading dates immediately preceding the March 1, 2025 grant date.

F7 · balance_after: The shares shall vest as follows: The 8,677 newly granted shares shall vest in one-third increments on each of March 1, 2026, March 1, 2027, and March 1, 2028. Additional shares shall vest as follows: 3,670 shares on March 1, 2026 and 1,721 shares on March 1, 2027. The remaining shares are vested.

SEC source: 0001179929-25-000032 · wk-form4_1741137540.xml · nonDerivative · entry 3

Keim Mark Lowell · CIK 0001690677 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,809

F4 · shares: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 5,273 shares on March 1, 2025.

F2 · price: Represents the closing price of the Issuer's common stock on February 28, 2025.

SEC source: 0001179929-25-000032 · wk-form4_1741137540.xml · nonDerivative · entry 2

Keim Mark Lowell · CIK 0001690677 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,289

F3 · shares: The shares were applied to payment of withholding taxes in connection with vesting of the above-mentioned performance stock units.

F2 · price: Represents the closing price of the Issuer's common stock on February 28, 2025.

SEC source: 0001179929-25-000032 · wk-form4_1741137540.xml · nonDerivative · entry 1

Keim Mark Lowell · CIK 0001690677 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,342

F1 · shares: Shares issued in settlement of performance stock units granted on March 1, 2022 based on the Company achievement of three-year average adjusted earnings per share at the 149% vesting level for the 2022 performance stock units.

F2 · price: Represents the closing price of the Issuer's common stock on February 28, 2025.

SEC source: 0001179929-25-000011 · wk-form4_1735856240.xml · nonDerivative · entry 1

BRASIER BARBARA L · CIK 0001169490 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,226

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2025, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2024, of $291.05. Thus, the grant this quarter for services as a Director is for 189 shares of the Issuer's common stock.

F3 · price: Represents the closing price of the Issuer's common stock on December 31, 2024.

SEC source: 0001179929-25-000018 · wk-form4_1735856519.xml · nonDerivative · entry 2

Bacon Debra · CIK 0002010075 · EVP, Medicaid

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,068

F3 · price: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 1,231 shares on January 1, 2025.

F4 · balance_after: The shares vest as follows: 1,249 shares on March 1, 2025; 530 shares on July 1, 2025; 1,003 shares on March 1, 2026; 529 shares on July 1, 2026; and 757 shares on March 1, 2027. The remaining shares are vested.

SEC source: 0001179929-25-000017 · wk-form4_1735856482.xml · nonDerivative · entry 1

Lockhart Stephen H · CIK 0001856013 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,792

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F3 · price: Represents the closing price of the Issuer's common stock on December 31, 2024.

F2 · acquired: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2025, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2024, of $291.05. Thus, the grant this quarter for services as a Director is for 189 shares of the Issuer's common stock.

SEC source: 0001179929-25-000016 · wk-form4_1735856439.xml · nonDerivative · entry 1

WOLF DALE B · CIK 0001228861 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,541

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2025, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2024, of $291.05. Thus, the grant this quarter for services as a Director is for 189 shares of the Issuer's common stock.

F3 · price: Represents the closing price of the Issuer's common stock on December 31, 2024.

SEC source: 0001179929-25-000015 · wk-form4_1735856401.xml · nonDerivative · entry 1

ORLANDO STEVEN J · CIK 0001211493 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 18,375

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2025, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2024, of $291.05. Thus, the grant this quarter for services as a Director is for 189 shares of the Issuer's common stock.

F3 · price: Represents the closing price of the Issuer's common stock on December 31, 2024.

F4 · ownership.nature: Shares are held by Orlando Family Trust.

SEC source: 0001179929-25-000014 · wk-form4_1735856365.xml · nonDerivative · entry 1

ROMNEY RONNA · CIK 0001206684 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 17,483

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2025, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2024, of $291.05. Thus, the grant this quarter for services as a Director is for 189 shares of the Issuer's common stock.

F3 · price: Represents the closing price of the Issuer's common stock on December 31, 2024.

F4 · ownership.nature: All shares held by Ronna Romney Revocable Trust.

SEC source: 0001179929-25-000013 · wk-form4_1735856311.xml · nonDerivative · entry 1

ZORETIC RICHARD C · CIK 0001263714 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 6,997

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2025, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2024, of $291.05. Thus, the grant this quarter for services as a Director is for 189 shares of the Issuer's common stock.

F3 · price: Represents the closing price of the Issuer's common stock on December 31, 2024.

F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust.

SEC source: 0001179929-25-000012 · wk-form4_1735856275.xml · nonDerivative · entry 1

Schapiro Richard M · CIK 0001649773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,745

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2025, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2024, of $291.05. Thus, the grant this quarter for services as a Director is for 189 shares of the Issuer's common stock.

F3 · price: Represents the closing price of the Issuer's common stock on December 31, 2024.

SEC source: 0001179929-25-000010 · wk-form4_1735856194.xml · nonDerivative · entry 1

COOPERMAN DANIEL · CIK 0001205008 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,327

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2025, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2024, of $291.05. Thus, the grant this quarter for services as a Director is for 189 shares of the Issuer's common stock.

F3 · price: Represents the closing price of the Issuer's common stock on December 31, 2024.

SEC source: 0001179929-25-000018 · wk-form4_1735856519.xml · nonDerivative · entry 1

Bacon Debra · CIK 0002010075 · EVP, Medicaid

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,518

F1 · kind: The shares were acquired under the Molina Healthcare, Inc. 2019 Employee Stock Purchase Plan (the "ESPP").

F2 · price: In accordance with the ESPP provisions, the purchase price is 85% of the closing price of the Issuers common stock on December 31, 2024 of $291.05, the last trading day of the ESPP offering period. The purchase price is based on the lower market price as of the two following dates: (i) July 1, 2024, the first day of the ESPP offering period, and (ii) December 31, 2024, the last day of the ESPP offering period.

SEC source: 0001179929-24-000153 · wk-form4_1732052296.xml · nonDerivative · entry 1

Schapiro Richard M · CIK 0001649773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,556

F1 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $292.60 to $293.30. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

SEC source: 0001179929-24-000145 · wk-form4_1727901925.xml · nonDerivative · entry 1

BRASIER BARBARA L · CIK 0001169490 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,037

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2024, was $341.91, which resulted in a grant of 161 shares.

F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2024.

SEC source: 0001179929-24-000144 · wk-form4_1727901897.xml · nonDerivative · entry 1

COOPERMAN DANIEL · CIK 0001205008 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,138

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2024, was $341.91, which resulted in a grant of 161 shares.

F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2024.

SEC source: 0001179929-24-000142 · wk-form4_1727901836.xml · nonDerivative · entry 1

WOLF DALE B · CIK 0001228861 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,352

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2024, was $341.91, which resulted in a grant of 161 shares.

F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2024.

SEC source: 0001179929-24-000143 · wk-form4_1727901868.xml · nonDerivative · entry 1

Lockhart Stephen H · CIK 0001856013 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,603

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2024, was $341.91, which resulted in a grant of 161 shares.

F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2024.

SEC source: 0001179929-24-000141 · wk-form4_1727901813.xml · nonDerivative · entry 1

ROMNEY RONNA · CIK 0001206684 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 17,294

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2024, was $341.91, which resulted in a grant of 161 shares.

F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2024.

F4 · ownership.nature: All shares held by Ronna Romney Revocable Trust.

SEC source: 0001179929-24-000140 · wk-form4_1727901783.xml · nonDerivative · entry 1

ORLANDO STEVEN J · CIK 0001211493 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 18,186

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2024, was $341.91, which resulted in a grant of 161 shares.

F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2024.

F4 · ownership.nature: Shares are held by Orlando Family Trust.

SEC source: 0001179929-24-000139 · wk-form4_1727901752.xml · nonDerivative · entry 1

Schapiro Richard M · CIK 0001649773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,692

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2024, was $341.91, which resulted in a grant of 161 shares.

F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2024.

SEC source: 0001179929-24-000138 · wk-form4_1727901705.xml · nonDerivative · entry 1

ZORETIC RICHARD C · CIK 0001263714 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 6,808

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2024, was $341.91, which resulted in a grant of 161 shares.

F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2024.

F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust.

SEC source: 0001179929-24-000129 · wk-form4_1723841626.xml · nonDerivative · entry 1

HEBERT MAURICE · CIK 0001267043 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,473

F1 · price: Represents the selling price per share of all 393 shares.

F2 · balance_after: The shares shall vest as follows: 901 shares shall vest on March 1, 2025, 501 shares shall vest on March 1, 2026, and 258 shares shall vest on March 1, 2027. The remaining shares are vested.

SEC source: 0001179929-24-000127 · wk-form4_1722372410.xml · nonDerivative · entry 1

ORLANDO STEVEN J · CIK 0001211493 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 18,025

F1 · price: Represents the actual selling price per share of all 1,000 shares.

F2 · ownership.nature: Shares are held by Orlando Family Trust.

SEC source: 0001179929-24-000126 · wk-form4_1722372330.xml · nonDerivative · entry 1

Barlow Jeff D. · CIK 0001555603 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,148

F1 · price: Represents the actual selling price per share of all 5,340 shares.

F2 · balance_after: The shares vest as follows: 3,738 shares on March 1, 2025; 2,563 shares on March 1, 2026; and 1,102 shares on March 1, 2027. The remaining shares are vested.

SEC source: 0001179929-24-000112 · wk-form4_1719953800.xml · nonDerivative · entry 1

BRASIER BARBARA L · CIK 0001169490 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,876

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2024, was $292.16, which resulted in a grant of 188 shares.

F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2024.

SEC source: 0001179929-24-000117 · wk-form4_1719954049.xml · nonDerivative · entry 1

Lockhart Stephen H · CIK 0001856013 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,442

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2024, was $292.16, which resulted in a grant of 188 shares.

F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2024.

SEC source: 0001179929-24-000116 · wk-form4_1719953991.xml · nonDerivative · entry 1

ZORETIC RICHARD C · CIK 0001263714 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 6,647

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2024, was $292.16, which resulted in a grant of 188 shares.

F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2024.

F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust.

SEC source: 0001179929-24-000115 · wk-form4_1719953956.xml · nonDerivative · entry 1

Schapiro Richard M · CIK 0001649773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,531

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2024, was $292.16, which resulted in a grant of 188 shares.

F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2024.